| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
35,030,000 |
| Market
Cap: |
17.52(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.331 - $0.8875 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Surrozen is a newly incorporated blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
777,140 |
777,140 |
777,140 |
777,140 |
| Total Buy Value |
$11,999,976 |
$11,999,976 |
$11,999,976 |
$11,999,976 |
| Total People Bought |
4 |
4 |
4 |
4 |
| Total Buy Transactions |
6 |
6 |
6 |
6 |
| Total Shares Sold |
0 |
0 |
0 |
5,382,499 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Consonance Capman Gp, Llc |
Director |
– • • |
2020-11-23 |
4 |
B |
$0.00 |
$0 |
I/I |
1,000,000 |
128,900 |
2.17 |
- |
|
| Consonance Life Sciences |
10% Owner |
– – • |
2020-11-23 |
4 |
B |
$0.00 |
$0 |
D/D |
410,000 |
410,000 |
2.37 |
- |
|
| Soffer Benny |
Director |
– • – |
2020-11-23 |
4 |
B |
$0.00 |
$0 |
I/I |
410,000 |
410,000 |
2.02 |
- |
|
| Blutt Mitchell J Md |
Director |
– • – |
2020-11-23 |
4 |
B |
$0.00 |
$0 |
I/I |
410,000 |
410,000 |
2.02 |
- |
|
| Livingston Kevin Harold |
Chief Financial Officer |
• – – |
2020-11-23 |
4 |
B |
$0.00 |
$0 |
I/I |
410,000 |
410,000 |
1.91 |
- |
|
| Blutt Mitchell J Md |
Director |
– • – |
2020-11-18 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
2,210,000 |
|
- |
|
| Soffer Benny |
Director |
– • – |
2020-11-18 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
2,210,000 |
|
- |
|
| Consonance Life Sciences |
Director |
– • – |
2020-11-18 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
2,210,000 |
|
- |
|
| Livingston Kevin Harold |
Chief Financial OfficerOfficer |
• – – |
2020-11-18 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
2,210,000 |
|
- |
|
| Soffer Benny |
Director |
– • – |
2020-11-18 |
4/A |
S |
$0.01 |
$981 |
I/I |
(90,000) |
2,210,000 |
|
- |
|
| Livingston Kevin Harold |
Chief Financial Officer |
• – – |
2020-11-18 |
4/A |
S |
$0.01 |
$981 |
I/I |
(90,000) |
2,210,000 |
|
- |
|
| Consonance Life Sciences |
Director |
– • – |
2020-11-18 |
4/A |
S |
$0.01 |
$981 |
D/D |
(90,000) |
2,210,000 |
|
- |
|
| Blutt Mitchell J Md |
Director |
– • – |
2020-11-18 |
4/A |
S |
$0.01 |
$981 |
I/I |
(90,000) |
2,210,000 |
|
- |
|
| Soffer Benny |
Director |
– • – |
2020-11-10 |
4/A |
D |
$0.00 |
$0 |
I/I |
(575,000) |
2,300,000 |
|
- |
|
| Livingston Kevin Harold |
Chief Financial Officer |
• – – |
2020-11-10 |
4/A |
D |
$0.00 |
$0 |
I/I |
(575,000) |
2,300,000 |
|
- |
|
| Consonance Life Sciences |
Director |
– • – |
2020-11-10 |
4/A |
D |
$0.00 |
$0 |
D/D |
(575,000) |
2,300,000 |
|
- |
|
| Blutt Mitchell J Md |
Director |
– • – |
2020-11-10 |
4/A |
D |
$0.00 |
$0 |
I/I |
(575,000) |
2,300,000 |
|
- |
|
| Soffer Benny |
Director |
– • – |
2020-10-08 |
4/A |
D |
$0.00 |
$0 |
I/I |
(718,750) |
2,875,000 |
|
- |
|
| Livingston Kevin Harold |
Chief Financial Officer |
• – – |
2020-10-08 |
4/A |
D |
$0.00 |
$0 |
I/I |
(718,750) |
2,875,000 |
|
- |
|
| Consonance Life Sciences |
Director |
– • – |
2020-10-08 |
4/A |
D |
$0.00 |
$0 |
D/D |
(718,750) |
2,875,000 |
|
- |
|
| Blutt Mitchell J Md |
Director |
– • – |
2020-10-08 |
4/A |
D |
$0.00 |
$0 |
I/I |
(718,750) |
2,875,000 |
|
- |
|
| Soffer Benny |
Director |
– • – |
2020-09-04 |
4/A |
A |
$0.01 |
$25,156 |
I/I |
3,593,750 |
3,593,750 |
|
- |
|
| Livingston Kevin Harold |
Chief Financial Officer |
• – – |
2020-09-04 |
4/A |
A |
$0.01 |
$25,156 |
I/I |
3,593,750 |
3,593,750 |
|
- |
|
| Consonance Life Sciences |
Director |
– • – |
2020-09-04 |
4/A |
A |
$0.01 |
$25,156 |
D/D |
3,593,750 |
3,593,750 |
|
- |
|
| Blutt Mitchell J Md |
Director |
– • – |
2020-09-04 |
4/A |
A |
$0.01 |
$25,156 |
I/I |
3,593,750 |
3,593,750 |
|
- |
|
75 Records found
|
|
Page 3 of 3 |
|
|
